As treatment for spinal muscular atrophy (SMA) has drastically improved over the last decade, so too have survival rates and the number of people with SMA living well into adulthood. | A new ...

Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 euros, and ...

Gambir Muhamad Alvino Febrian Winata Student at sma pgri gelumbang Palembang sma pgri gelumbang ...

GitHub is where people build software. More than 150 million people use GitHub to discover, fork, and contribute to over 420 million projects.